
The launch of many brand-name drugs and an increased volume ofprescriptions written for Medicaid enrollees between 1997 and 2002were responsible for a doubling of Medicaid expenditures duringthis time period, according to a new report from the Agency forHealthcare Research & Quality (AHRQ). At the same time, the useof generics fell from 47% to 44%.